Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoni Ribas

Showing results (11-20 of 467) with videos related to

Pageof 47
Sort By:
Update on Cancer Therapeutics|June 23, 2009
Anti-CTLA4 Antibody Clinical Trials in MelanomaAntoni Ribas
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Combination Therapies Building on the Efficacy of CTLA4 and BRAF Inhibitors for Metastatic MelanomaAntoni Ribas
Journal for Immunotherapy of Cancer|May 27, 2025
Basic rules to respond to PD-1 blockade cancer immunotherapyAntoni Ribas
Cancer Discovery|May 12, 2012
Q&A: Antoni Ribas on immunotherapy progressAntoni Ribas
Journal of the National Comprehensive Cancer Network : JNCCN|August 4, 2006
Update on immunotherapy for melanomaAntoni Ribas
The New England Journal of Medicine|September 9, 2015
Releasing the Brakes on Cancer ImmunotherapyAntoni Ribas
Therapeutic Advances in Medical Oncology|January 12, 2016
Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapyZeynep Eroglu, Antoni Ribas
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 21, 2018
Antigen Presentation Keeps Trending in Immunotherapy ResistanceAnusha Kalbasi, Antoni Ribas
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
Targeted therapies to improve tumor immunotherapyJonathan Begley, Antoni Ribas
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 7, 2025
Molecular Determinants of Immunotherapy Efficacy in Mesothelioma: A Step Toward Precision OncologyHaining Yang, Antoni Ribas
Pageof 47

Showing results (11-20 of 467) with videos related to

Sort By:
Pageof 47
Update on Cancer Therapeutics|June 23, 2009
Anti-CTLA4 Antibody Clinical Trials in MelanomaAntoni Ribas
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Combination Therapies Building on the Efficacy of CTLA4 and BRAF Inhibitors for Metastatic MelanomaAntoni Ribas
Journal for Immunotherapy of Cancer|May 27, 2025
Basic rules to respond to PD-1 blockade cancer immunotherapyAntoni Ribas
Cancer Discovery|May 12, 2012
Q&A: Antoni Ribas on immunotherapy progressAntoni Ribas
Journal of the National Comprehensive Cancer Network : JNCCN|August 4, 2006
Update on immunotherapy for melanomaAntoni Ribas
The New England Journal of Medicine|September 9, 2015
Releasing the Brakes on Cancer ImmunotherapyAntoni Ribas
Therapeutic Advances in Medical Oncology|January 12, 2016
Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapyZeynep Eroglu, Antoni Ribas
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 21, 2018
Antigen Presentation Keeps Trending in Immunotherapy ResistanceAnusha Kalbasi, Antoni Ribas
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
Targeted therapies to improve tumor immunotherapyJonathan Begley, Antoni Ribas
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 7, 2025
Molecular Determinants of Immunotherapy Efficacy in Mesothelioma: A Step Toward Precision OncologyHaining Yang, Antoni Ribas
Pageof 47